Research Grade Anti-MERS-CoV RBD Antibody (REGN3051)
Anti-MERS-CoV RBD Antibody (REGN3051) ( VK800016 ) is a research-grade recombinant antibody targeting RBD . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.
Спецификация
| Species reactivity | Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Form | Liquid |
| Storage | -20℃ |
| Product category | Biosimilar |
| Target | RBD |
| Accession | K9N5Q8 |
| Host species | Human |
| | |
Информация для заказа
| Область использования: | Производство: | Puda Scientific |
| Метод: | Иммуногистохимия |
| Объем: | 1mg |
| Кат. номер: | PD-A26-496-100 |
| Цена (с НДС 22%): | по запросу | В корзину  |
Наименование: Research Grade Anti-MERS-CoV RBD Antibody (REGN3051).
Примечание: |
